AIKIDNEY
LIVE

Serial Number

97980612

Owner

CAREDX TRANSPLANT MANAGEMENT, INC.

Attorney

Theresa Conduah

First Use Date

Jan 31, 2023

Filing Date

Jun 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AIKIDNEY Trademark

Serial Number: 97980612 • Registration: 8005591

AIKIDNEY is a trademark filed by CAREDX TRANSPLANT MANAGEMENT, INC. on June 16, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CAREDX TRANSPLANT MANAGEMENT, INC. (14 trademarks)

8000 MARINA BOULEVARD, FLOOR 4
BRISBANE, CA 94005

Entity Type: 03

CareDx Transplant Managment, Inc. (5 trademarks)

10202 F Street
Omaha, NE 68127

Entity Type: 03

Trademark Details

Filing Date

June 16, 2022

Registration Date

October 28, 2025

First Use Anywhere

January 31, 2023

First Use in Commerce

January 31, 2023

Published for Opposition

January 2, 2024

Goods & Services

Providing online, non-downloadable software for use in informing clinical patient management in the medical and health care fields; Providing online, non-downloadable software for use in monitoring and analyzing patient healthcare information, allograft health and medical risk profile; Providing online, non-downloadable software for use in predictive analytics, health assessment, allograft assessment, medical risk assessment and medical risk probabilities; Providing online, non-downloadable software for use with an electronic medical record system; Providing online, non-downloadable software that enable users to input, view, track, aggregate, analyze, monitor and manage patient healthcare information and data for patient medical assessments; Providing online, non-downloadable software that include algorithms for use in the medical and healthcare fields; Providing online, non-downloadable software that include algorithms using molecular biomarkers for predictive analytics in the medical and healthcare fields; Providing online, non-downloadable software that conducts predictive and risk analytics for use in the medical and healthcare fields; Providing temporary use of non-downloadable cloud based software for use in informing clinical patient management in the medical and health care fields; Providing temporary use of non-downloadable cloud based software for use in monitoring and analyzing patient healthcare information, allograft health and medical risk profile; Providing temporary use of non-downloadable cloud based software for use in predictive analytics, health assessment, allograft assessment, medical risk assessment and medical risk probabilities; Providing temporary use of non-downloadable cloud based software for use with an electronic medical record system; Providing temporary use of non-downloadable cloud based software that enable users to input, view, track, aggregate, analyze, monitor and manage patient healthcare information and data for patient medical assessments; Providing temporary use of non-downloadable cloud based software that include algorithms for use in the medical and healthcare fields; Providing temporary use of non-downloadable cloud based software that include algorithms using molecular biomarkers for predictive analytics in the medical and healthcare fields; Providing temporary use of non-downloadable cloud based software that conducts predictive and risk analytics for use in the medical and healthcare fields; Software as a service (SaaS) services featuring software for use in informing clinical patient management in the medical and health care fields; Software as a service (SaaS) services featuring software for use in monitoring and analyzing patient healthcare information, allograft health and medical risk profile; Software as a service (SaaS) services featuring software for use in predictive analytics, health assessment, allograft assessment, medical risk assessment and medical risk probabilities; Software as a service (SaaS) services featuring software for use with an electronic medical record system; Software as a service (SaaS) services featuring software that enable users to input, view, track, aggregate, analyze, monitor and manage patient healthcare information and data for patient medical assessments; Software as a service (SaaS) services featuring software that include algorithms for use in the medical and healthcare fields; Software as a service (SaaS) services featuring software that include algorithms using molecular biomarkers for predictive analytics in the medical and healthcare fields; Software as a service (SaaS) services featuring software that conducts predictive and risk analytics for use in the medical and healthcare fields

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 28, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 28, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 4, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 4, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 18, 2025 SUPC
DIVISIONAL PROCESSING COMPLETE
Sep 18, 2025 DPCC
USE AMENDMENT FILED
Aug 22, 2025 IUAF
DIVISIONAL REQUEST RECEIVED
Aug 22, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Aug 22, 2025 ERTD
TEAS STATEMENT OF USE RECEIVED
Aug 22, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 25, 2025 EXRA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 24, 2025 CHAN
SOU EXTENSION 2 GRANTED
Jul 24, 2025 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 24, 2025 AITU
TEAS POST PUBLICATION AMENDMENT RECEIVED
Mar 4, 2025 EPPA
SOU EXTENSION 2 FILED
Feb 13, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 13, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2024 EXRA
SOU EXTENSION 1 GRANTED
Aug 27, 2024 EX1G
SOU EXTENSION 1 FILED
Aug 27, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 27, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 26, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 26, 2024 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 27, 2024 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 12, 2024 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 24, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 22, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 27, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 27, 2023 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 28, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 22, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 7, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 4, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 4, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 4, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 4, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 29, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 29, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 29, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2022 NWOS
NEW APPLICATION ENTERED
Jun 20, 2022 NWAP